Conexeu Sciences Inc. (CNXU)
NASDAQ: CNXU · Real-Time Price · USD
10.34
+0.10 (0.98%)
Jul 9, 2026, 1:50 PM EDT - Market open
Conexeu Sciences Market Cap
Conexeu Sciences has a market cap or net worth of $276.68 million as of July 9, 2026.
Market Cap
276.68M
Enterprise Value
267.16M
1-Year Change
n/a
Ranking
Category
Stock Price
$10.34
Market Cap Chart
Since May 21, 2026, Conexeu Sciences's market cap has decreased from $330.28M to $276.68M, a decrease of -16.23%. That is a compound annual growth rate of -73.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 276.68M | 0.98% |
| Jul 8, 2026 | 274.01M | 7.90% |
| Jul 7, 2026 | 253.94M | -12.13% |
| Jul 6, 2026 | 288.99M | -0.55% |
| Jul 2, 2026 | 290.60M | 5.85% |
| Jul 1, 2026 | 274.54M | -6.04% |
| Jun 30, 2026 | 292.20M | 6.64% |
| Jun 29, 2026 | 274.01M | -6.57% |
| Jun 26, 2026 | 293.27M | 7.24% |
| Jun 25, 2026 | 273.47M | -4.40% |
| Jun 24, 2026 | 286.05M | 1.33% |
| Jun 23, 2026 | 282.30M | -13.38% |
| Jun 22, 2026 | 325.92M | -8.28% |
| Jun 18, 2026 | 355.35M | 2.00% |
| Jun 17, 2026 | 348.39M | 3.99% |
| Jun 16, 2026 | 335.01M | 27.49% |
| Jun 15, 2026 | 262.77M | -7.90% |
| Jun 12, 2026 | 285.30M | -6.92% |
| Jun 11, 2026 | 306.53M | -6.84% |
| Jun 10, 2026 | 329.02M | -6.60% |
| Jun 9, 2026 | 352.26M | -8.71% |
| Jun 8, 2026 | 385.87M | 0.17% |
| Jun 5, 2026 | 385.23M | -4.72% |
| Jun 4, 2026 | 404.32M | -5.04% |
| Jun 3, 2026 | 425.80M | 0.06% |
| Jun 2, 2026 | 425.55M | 19.26% |
| Jun 1, 2026 | 356.81M | 20.43% |
| May 29, 2026 | 296.29M | 1.25% |
| May 28, 2026 | 292.63M | -15.01% |
| May 27, 2026 | 344.30M | -1.05% |
| May 26, 2026 | 347.97M | -4.38% |
| May 22, 2026 | 363.89M | 10.18% |
| May 21, 2026 | 330.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adagene | 259.00M |
| Coherus Oncology | 258.37M |
| AC Immune | 254.45M |
| Nkarta | 253.27M |
| Fulcrum Therapeutics | 252.54M |
| Anavex Life Sciences | 251.14M |
| Protara Therapeutics | 249.83M |
| Sol-Gel Technologies | 245.21M |